Li and colleagues [9] focused on MET receptor, using various antibody fragments derived from an anti-MET antibody to obtain images of non-small-cell lung cancer xenografts from cell lines resistant to targeted anti-EGFR therapy due to the overexpression of MET. This evidence concerns the gene MET and non-small cell lung carcinoma.